Chiusura precedente | 4,7500 |
Aperto | 4,8400 |
Denaro | N/D x N/D |
Lettera | N/D x N/D |
Min-Max giorno | 4,7600 - 4,8900 |
Intervallo di 52 settimane | 1,8500 - 6,5800 |
Volume | |
Media Volume | 136.345 |
Capitalizzazione | 168,642M |
Beta (5 anni mensile) | 0,81 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -1,2000 |
Prossima data utili | N/D |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 13,90 |
Eindhoven, Netherlands, Oct. 11, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injury, today announced that it will host a webcast to discuss its Q3 2023 business highlights. The webcast will be held on November 16, 2023, at 2:00PM CET / 08:00AM ET. It will be hosted by CEO Dave Marver and CFO Khaled Bahi, who will discuss highlights from Q3 202
Pioneering procedure pairs Company’s investigational ARC-IM implantable spinal cord stimulator with an investigational brain-computer interfaceEindhoven, Sept. 27, 2023 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces the successful first-in-human implant of its ARC-IM Stimulator*, to restore upper e
Eindhoven, Sept. 19, 2023 (GLOBE NEWSWIRE) -- THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) US commercialization of ARC-EX™ expected 2H 2024 with USD 30,000 anticipated price Clinical study initiated pairing ARC Therapy™ with a brain-computer interface to restore use of legs and upper extremities ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movem